EN

Informator o strukturze Uczelni

Rozwiń
Strona główna jednostki
Publikacje (lista filadelfijska)
Profil
Prowadzone projekty badawcze
Start > Organizacja uczelni  > Podstawowe jednostki strukturalne  > Wydział Lekarski  > Katedra i Klinika Onkologii i Radioterapii

Katedra i Klinika Onkologii i Radioterapii

Wydział Lekarski

PUBLIKACJE (LISTA FILADELFIJSKA)

Publikacje w czasopismach z "listy filadelfijskiej" (z trzech ostatnich lat):

  1. Patient and public involvement in research: reflections and experiences of doctoral cancer nurse researchers in Europe - Tanay M.A., Díez de los Ríos de la Serna C., Boland V., Lopes A.M.D.S., Dornan M., Wingfield K., Yildiz G., Chircop D., SUCHODOLSKA GRAŻYNA, Kurt B., Colomer-Lahiguera S.. - Ann. Oncol. - 2022 : vol. 33, suppl. 7, s. S1364
  2. Mobile applications for early breast cancer chemotherapy-related symptoms reporting and management : a scoping review - SUCHODOLSKA GRAŻYNA, SENKUS ELŻBIETA. - Cancer Treat. Rev. - 2022 : vol. 105, art. ID 102364, s. 1-9, bibliogr. 38 poz., streszcz. ang.
  3. Profound neutropenia related to consolidation durvalumab treatment following concurrent radiochemotherapy in a patient with stage III nonsmall-cell lung cancer - BANDURA ARTUR, KURLAPSKI MICHAŁ, KAMIŃSKA MAŁGORZATA, DZIADZIUSZKO RAFAŁ, JASSEM JACEK. - Pol. Arch. Med. Wewn. - 2022 : vol. 132, nr 2, art. ID 16161, s. 1-2, bibliogr. 5 poz.
  4. ESO-ESMO fifth international consensus guidelines for breast cancer in young women (BCY5) - Paluch-Shimon S., Cardoso F., Partridge A. H., Abulkhair O., Azim H. A., Bianchi-Micheli G., Cardoso M. J., Curigliano G., Gelmon K. A., Gentilini O., Harbeck N., Kaufman B., Kim S. B., Liu Q., Merschdorf J., Poortmans P., Pruneri G., SENKUS ELŻBIETA, Sirohi B., Spanic T., Sulosaari V., Peccatori F., Pagani O.. - Ann. Oncol. - 2022 : vol. 33, nr 11, s. 1097-1118, bibliogr. 166 poz., streszcz. ang.
  5. ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer - Passaro A., Leighl N., Blackhall F., Popat S., Kerr K., Ahn M. J., Arcila M. E., Arrieta O., Planchard D., de Marinis F., Dingemans A. M., DZIADZIUSZKO RAFAŁ, Faivre-Finn C., Feldman J., Felip E., Curigliano G., Herbst R., Jänne P. A., John T., Mitsudomi T., Mok T., Normanno N., Paz-Ares L., Ramalingam S., Sequist L., Vansteenkiste J., Wistuba I. I., Wolf J., Wu Y. L., Yang S. R., Yang J. C. H., Yatabe Y., Pentheroudakis G., Peters S.. - Ann. Oncol. - 2022 : vol. 33, nr 5, s. 466-487, bibliogr. 177 poz., streszcz. ang.
  6. Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer - Van Baelen K., Geukens T., Maetens M., Tjan-Heijnen V., Lord C. J., Linn S., Bidard F.-C., Richard F., Yang W. W., Steele R. E., Pettitt S. J., Van Ongeval C., De Schepper M., Isnaldi E., Nevelsteen I., Smeets A., Punie K., Voorwerk L., Wildiers H., Floris G., Vincent-Salomon A., Derksen P. W. B., Neven P., SENKUS ELŻBIETA, Sawyer E., Kok M., Desmedt C.. - Ann. Oncol. - 2022 : vol. 33, nr 8, s. 769-785, bibliogr. 210 poz., streszcz. ang.
  7. Adding a platinum agent to neoadjuvant chemotherapy for triple-negative breast cancer: the die has not been cast - TOMASIK BARTŁOMIEJ, BIEŃKOWSKI MICHAŁ, JASSEM JACEK. - Ann. Oncol. - 2022 : vol. 33, nr 6, s. 658-659, bibliogr. 8 poz.
  8. Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer - Geyer, Jr. C. E., Garber J. E., Gelber R. D., Yothers G., Taboada M., Ross L., Rastogi P., Cui K., Arahmani A., Aktan G., Armstrong A. C., Arnedos M., Balmana J., Bergh J., Bliss J., Delaloge S., Domchek S. M., Eisen A., Elsafy F., Fein L. E., Fielding A., Ford J. M., Friedman S., Gelmon K. A., Gianni L., Gnant M., Hollingsworth S. J., Im S.-A., Jager A., Jóhannsson Ó. P., Lakhani S. R., Janni W., Linderholm B., Liu T.-W., Loman N., Korde L., Loibl S., Lucas P. C., Marmé F., Martinez de Duenas E., McConnell R., Phillips K.-A., Piccart M., Rossi G., Schmutzler R., SENKUS ELŻBIETA, Shao Z., Sharma P., Singer C. F., Španić T., Stickeler E., Toi M., Traina T. A., Viale G., Zoppoli G., Park Y. H., Yerushalmi R., Yang H., Pang D., Jung K. H., Mailliez A., Fan Z., Tennevet I., Zhang J., Nagy T., Sonke G. S., Sun Q., Parton M., Colleoni M. A., Schmidt M., Brufsky A. M., Razaq W., Kaufman B., Cameron D., Campbell C., Tutt A. N. J.. - Ann. Oncol. - 2022 : vol. 33, nr 12, s. 1250-1268, bibliogr. 31 poz., streszcz. ang.
  9. Assessment of cervical vascularization density in patients with locally advanced squamous cell cervical carcinoma evaluated in colour Doppler and power Doppler functions - Tomalczyk Adam, TOMASIK BARTŁOMIEJ, Fijuth Jacek, Moszyńska-Zielińska Małgorzata, Gottwald Leszek. - Arch. Gynecol. Obstet. - 2022 : vol. 305, nr 4, s. 955-961, bibliogr. 24 poz., streszcz. ang.
  10. Assessment of cervical vascularization density in patients with locally advanced squamous cell cervical carcinoma evaluated in colour Doppler and power Doppler functions - Tomalczyk Adam, TOMASIK BARTŁOMIEJ, Fijuth Jacek, Moszynska-Zielinska Malgorzata, Gottwald Leszek. - Arch. Gynecol. Obstet. - 2022 : vol. 305, nr 4, s. 955-961, bibliogr. 24 poz., streszcz. ang.
  11. Ultra-hypofractionated stereotactic body radiotherapy for localized prostate cancer: clinical outcomes, patterns of recurrence, feasibility of definitive salvage treatment, and competing oncological risk - Miszczyk Marcin, Szołtysik Monika, Hasterok Maja, Goldner Gregor, Rajwa Paweł, Namysł-Kaletka Agnieszka, Napieralska Aleksandra, Kraszkiewicz Małgorzata, Stąpór-Fudzińska Małgorzata, TOMASIK BARTŁOMIEJ, Woźniak Grzegorz, Głowacki Grzegorz, Kaminiów Konrad, Moll Matthias, Magrowski Łukasz, Majewski Wojciech. - Biomedicines - 2022 : vol. 10, nr 10, art. ID 2446, s. 1-12, bibliogr. 36 poz., streszcz. ang.
  12. Current challenges and unmet needs in treating patients with human epidermal growth factor receptor 2-positive advanced breast cancer - Aapro Matti, Cardoso Fatima, Curigliano Giuseppe, Eniu Alexandru, Gligorov Joseph, Harbeck Nadia, Mueller Andreas, Pagani Olivia, Paluch-Shimon Shani, SENKUS-KONEFKA ELŻBIETA, Thürlimann Beat, Zaman Khalil. - Breast - 2022 : vol. 66, s. 145-156, bibliogr. 107 poz., streszcz. ang.
  13. Detection and localization of early- and late-stage cancers using platelet RNA - In 't Veld Sjors G. J. G., Arkani Mohammad, Post Edward, Antunes-Ferreira Mafalda, DAmbrosi Silvia, Vessies Daan C. L., Vermunt Lisa, Vancura Adrienne, Muller Mirte, Niemeijer Anna-Larissa N., Tannous Jihane, Meijer Laura L., Le Large Tessa Y. S., Mantini Giulia, Wondergem Niels E., Heinhuis Kimberley M., van Wilpe Sandra, Smits A. Josien, Drees Esther E. E., Roos Eva, Leurs Cyra E., Tjon Kon Fat Lee-Ann, van der Lelij Ewoud J., Dwarshuis Govert, Kamphuis Maarten J., Visser Lisanne E., Harting Romee, Gregory Annemijn, Schweiger Markus W., Wedekind Laurine E., Ramaker Jip, Zwaan Kenn, Verschueren Heleen, Bahce Idris, de Langen Adrianus J., Smit Egbert F., van den Heuvel Michel M., Hartemink Koen J., Kuijpers Marijke J. E., oude Egbrink Mirjam G. A., Griffioen Arjan W., Rossel Rafael, Hiltermann T. Jeroen N., Lee-Lewandrowski Elizabeth, Lewandrowski Kent B., De Witt Hamer Philip C., Kouwenhoven Mathilde, Reijneveld Jaap C., Leenders William P. J., Hoeben Ann, Verdonck-de Leeuw Irma M., Leemans C. René, Baatenburg de Jong Robert J., Terhaard Chris H. J., Takes Robert P., Langendijk Johannes A., de Jager Saskia C., Kraaijeveld Adriaan O., Pasterkamp Gerard, Smits Minke, Schalken Jack A., ŁAPIŃSKA-SZUMCZYK SYLWIA, ŁOJKOWSKA ANNA, ŻACZEK ANNA J., Lokhorst Henk, van de Donk Niels W. C. J., Nijhof Inger, Prins Henk-Jan, Zijlstra Josée M., Idema Sander, Baayen Johannes C., Teunissen Charlotte E., Killestein Joep, Besselink Marc G., Brammen Lindsay, Bachleitner-Hofmann Thomas, Mateen Farrah, Plukker John T. M., Heger Michal, de Mast Quirijn, Lisman Ton, Pegtel D. Michiel, Bogaard Harm-Jan, JASSEM JACEK, SUPERNAT ANNA, Mehra Niven, Gerritsen Winald, de Kroon Cornelis D., Lok Christianne A. R., Piek Jurgen M. J., Steeghs Neeltje, van Houdt Winan J., Brakenhoff Ruud H., Sonke Gabe S., Verheul Henk M., Giovannetti Elisa, Kazemier Geert, Sabrkhany Siamack, Schuuring Ed, Sistermans Erik A., Wolthuis Rob, Meijers-Heijboer Hanne, Dorsman Josephine, Oudejans Cees, Ylstra Bauke, Westerman Bart A., van den Broek Daan, Koppers-Lalic Danijela, Wesseling Pieter, Nilsson R. Jonas A., Vandertop W. Peter, Noske David P., Tannous Bakhos A., Sol Nik, Best Myron G., Wurdinger Thomas. - Cancer Cell - 2022 : vol. 40, nr 9, s. 999-1009.e6, bibliogr. [44] poz., streszcz. ang.
  14. PARP inhibitors for metastatic castration-resistant prostate cancer: biological rationale and current evidence - BIEŃKOWSKI MICHAŁ, TOMASIK BARTŁOMIEJ, Braun Marcin, JASSEM JACEK. - Cancer Treat. Rev. - 2022 : vol. 104, art. ID 102359, s. 1-12, bibliogr. 151 poz., streszcz. ang.
  15. Radiotherapy for leptomeningeal carcinomatosis in breast cancer patients: a narrative review - PAWŁOWSKA EWA, Romanowska Anna, JASSEM JACEK. - Cancers - 2022 : vol. 14, nr 16, art. ID 3899, s. 1-18, bibliogr. 71 poz., streszcz. ang.
  16. New genetic technologies in diagnosis and treatment of cancer of unknown primary - Krawczyk Paweł, JASSEM JACEK, Wojas-Krawczyk Kamila, Krzakowski Maciej, DZIADZIUSZKO RAFAŁ, Olszewski Włodzimierz. - Cancers - 2022 : vol. 14, nr 14, art. ID 3429, s. 1-13, bibliogr. 76 poz., streszcz. ang.
  17. The influence of radiotherapy on the function of the left and right ventricles in relation to the radiation dose administered to the left anterior descending coronary artery - from a cardiologists point of view - NABIAŁEK-TROJANOWSKA IZABELA, Sinacki Marcin, JANKOWSKA HANNA, LEWICKA-POTOCKA ZUZANNA, DZIADZIUSZKO RAFAŁ, LEWICKA EWA. - Cancers - 2022 : vol. 14, nr 10, art. ID 2420, s. 1-13, bibliogr. 33 poz., streszcz. ang.
  18. Management strategies for hyperglycemia associated with the α-selective PI3K inhibitor alpelisib for the treatment of breast cancer - Tankova Tsvetalina, SENKUS ELŻBIETA, Beloyartseva Maria, Borštnar Simona, Catrinoiu Doina, Frolova Mona, Hegmane Alinta, Janež Andrej, Krnić Mladen, Lengyel Zoltan, Marcou Yiola, Mazilu Laura, Mrinakova Bela, Percik Ruth, Petrakova Katarina, Rubovszky Gábor, Tokar Margarita, Vrdoljak Eduard. - Cancers - 2022 : vol. 14, nr 7, art. ID 1598, s. 1-14, bibliogr. 56 poz., streszcz. ang.
  19. Updated integrated analysis of the efficacy and safety of entrectinib in patients with NTRK fusion-positive solid tumors - Demetri George D., de Braud Filippo, Drilon Alexander, Siena Salvatore, Patel Manish R., Cho Byoung Chul, Liu Stephen V., Ahn Myung-Ju, Chiu Chao-Hua, Lin Jessica J., Goto Koichi, Lee Jeeyun, Bazhenova Lyudmila, John Thomas, Fakih Marwan, Chawla Sant P., DZIADZIUSZKO RAFAŁ, Seto Takashi, Heinzmann Sebastian, Pitcher Bethany, Chen David, Wilson Timothy R., Rolfo Christian. - Clin. Cancer Res. - 2022 : vol. 28, nr 7, s. 1302-1312, bibliogr. 21 poz., streszcz. ang.
  20. Circulating cell-free DNA as a prognostic biomarker in patients with advanced ALK+ non-small cell lung cancer in the global phase III ALEX trial - DZIADZIUSZKO RAFAŁ, Peters Solange, Mok Tony, Camidge D. Ross, Gadgeel Shirish M., Ou Sai-Hong Ignatius, KONOPA KRZYSZTOF, Noé Johannes, Nowicka Malgorzata, Bordogna Walter, Morcos Peter N., Smoljanovic Vlatka, Shaw Alice T.. - Clin. Cancer Res. - 2022 : vol. 28, nr 9, s. 1800-1808, bibliogr. 29 poz., streszcz. ang.
  21. Role of postoperative radiotherapy in the management for resected NSCLC -decision criteria in clinical routine pre- and post-lungART - Süveg Krisztian, Le Pechoux Cecile, Faivre-Finn Corinne, Putora Paul M., De Ruysscher Dirk, Widder Joachim, Van Houtte Paul, Troost Esther G.C., Slotman Ben J., Ramella Sara, Pöttgen Christoph, Peeters Stephanie T.H., Nestle Ursula, McDonald Fiona, DZIADZIUSZKO RAFAŁ, Belderbos José, Ricardi Umberto, Manapov Farkhad, Lievens Yolande, Geets Xavier, Dieckmann Karin, Guckenberger Matthias, Andratschke Nicolaus, Glatzer Markus. - Clin. Lung Cancer - 2022 : vol. 22, nr 6, s. 579-586, bibliogr. 51 poz., streszcz. ang.
  22. Impact of tobacco smoking on outcomes of radiotherapy: a narrative review - PERDYAN ADRIAN, JASSEM JACEK. - Curr. Oncol. - 2022 : vol. 29, nr 4, s. 2284-2300, bibliogr. 69 poz., streszcz. ang.
  23. Tepotinib for advanced non-small-cell lung cancer with MET exon 14 skipping mutations - BŁASZKOWSKA MAGDALENA, SPECHT-SZWOCH ZOFIA, DZIADZIUSZKO RAFAŁ. - ESMO Open - 2022 : vol. 7, nr 2, art. ID 100449, s. 1-2, bibliogr. 9 poz.
  24. Clinical experience and management of adverse events in patients with advanced ALK-positive non-small-cell lung cancer receiving alectinib - DZIADZIUSZKO RAFAŁ, Peters S., Ruf T., Cardona A., Guerini E., Kurtsikidze N., Smoljanovic V., Planchard D.. - ESMO Open - 2022 : vol. 7, nr 6, art. ID 100612, s. 1-10, bibliogr. 40 poz., streszcz. ang.
  25. Final efficacy and safety data, and exploratory molecular profiling from the phase III ALUR study of alectinib versus chemotherapy in crizotinibpretreated ALK-positive non-small-cell lung cancer - Wolf J., Helland Å, Oh I.-J., Migliorino M. R., DZIADZIUSZKO RAFAŁ, WRONA ANNA, de Castro J., Mazieres J., Griesinger F., Chlistalla M., Cardona A., Ruf T., Trunzer K., Smoljanovic V., Novello S.. - ESMO Open - 2022 : vol. 7, nr 1, art. ID 100333, s. 1-8, bibliogr. 29 poz., streszcz. ang.
  26. The need for a comprehensive and integrated approach to lung cancer policy in Europe - Racovita Monica, Wheeler Eleanor, Wait Suzanne, Albreht Tit, Baird Anne-Marie, JASSEM JACEK, McNamara Aoife, Novello Silvia, Radu-Loghin Cornel, Van Meerbeeck Jan P.. - Eur. J. Cancer - 2022 : vol. 175, s. 54-59, bibliogr. 30 poz., streszcz. ang.
  27. Case report: TFE3 positive Xp11.2 translocation renal cell carcinoma (TRCC) : a case study and review of the literature - Miroński Ignacy, Zaucha Jan Mateusz, KOWALSKI JACEK, ZAUCHA RENATA. - Front. Oncol. - 2022 : vol. 11, art. ID 826325, s. 1-7, bibliogr. 33 poz., streszcz. ang.
  28. Replication stress: a review of novel targets to enhance radiosensitivity - from bench to clinic - Zhang Yuewen, Wu Lei, Wang Zhao, Wang Jinpeng, Roychoudhury Shrabasti, TOMASIK BARTŁOMIEJ, Wu Gang, Wang Geng, Rao Xinrui, Zhou Rui. - Front. Oncol. - 2022 : vol. 12, art. ID 838637, s. 1- 23, bibliogr. 227 poz., streszcz. ang.
  29. Towards better pharmaceutical provision in Europe - who decides the future? - Horgan Denis, Spanic Tanja, Apostolidis Kathi, Curigliano Giuseppe, Chorostowska-Wynimko Joanna, Dauben Hans-Peter, Lal Jonathan A., DZIADZIUSZKO RAFAŁ, Mayer-Nicolai Christine, Kozaric Marta, Jönsson Bengt, Gutierrez-Ibarluzea Inaki, Fandel Marie-Helene, Lopert Ruth. - Healthcare (Basel) - 2022 : vol. 10, nr 8, art. ID 1594, s. 1-17, bibliogr. 75 poz., streszcz. ang.
  30. The role of 3D printing in planning complex medical procedures and training of medical professionals - cross-sectional multispecialty review - MEYER-SZARY JAROSŁAW, SOUZA LUIS MARLON, Mikulski Szymon, PATEL AGASTYA, Schulz Finn, TRETIAKOW DMITRY, FERCHO JUSTYNA, JAGUSZEWSKA KINGA, FRANKIEWICZ MIKOŁAJ, PAWŁOWSKA EWA, Targoński Radosław, Szarpak Łukasz, Dądela Katarzyna, SABINIEWICZ ROBERT, KWIATKOWSKA JOANNA. - Int. J. Environ. Res. Public Health - 2022 : vol. 19, nr 6, art. ID 3331, s. 1-38, bibliogr. 188 poz., streszcz. ang.
  31. Complementary and alternative therapies in oncology - Dawczak-Dębicka Agnieszka, Kufel-Grabowska Joanna, Bartoszkiewicz Mikołaj, PERDYAN ADRIAN, JASSEM JACEK. - Int. J. Environ. Res. Public Health - 2022 : vol. 19, nr 9, art. ID 5071, s. 1-15, bibliogr. 108 poz., streszcz. ang.
  32. Being a young radiation oncologist in Poland : results of a multi-institutional survey - PAWŁOWSKA EWA, Tomasik Bartlomiej, Spałek Mateusz, Chyrek Artur J., Napieralska Aleksandra. - J. Cancer Educ. - 2022 : vol. 37, nr 6, s. 1614-1620, bibliogr. 17 poz., streszcz. ang.
  33. ESO-ESSO-ESTRO multidisciplinary course in oncology for medical students : 4 years of experience (20162019) - Pavlidis Nicholas, Madry Radoslaw, Peeters Marc, Sandrucci Sergio, Markowska Janina, Peccatori Fedro, Costa Alberto, Eriksen Jesper Grau, Ricardi Umberto, Poetter Richard, Schrijvers Drisk, Vermorken Jan B., , SENKUS-KONEFKA ELŻBIETA. - J. Cancer Educ. - 2022 : vol. 37, nr 4, s. 1239-1244, bibliogr. 28 poz., streszcz. ang.
  34. Cancer care for Ukrainian refugees: strategic impact assessments in the early days of the conflict - Van Hemelrijck M., Fox L., Beyer K., Fedaraviciute E., George G., Hadi H., Haire A., Handford J., Mera A., Monroy-Iglesias M. J., Moss C. L., Perdek N., Russell B., Santaolalla A., Sztankay M., Wylie H., JASSEM JACEK, Zubaryev M., Anderson B. O., Ortiz R., Ilbawi A., Camacho R., Ferreira-Borges C., Roitberg F., Dvaladze A. E., Lasierra Losada M., Alves da Costa F., Aggarwal A., Lawler M., Kopetskiy S., Sullivan R.. - J. Cancer Policy - 2022 : vol. 34, art. ID 100370, s. 1-8, bibliogr. 41 poz., streszcz. ang.
  35. Management of pheochromocytomas and paragangliomas: a case-based review of clinical aspects and perspectives - Sobocki Bartosz Kamil, PERDYAN ADRIAN, Szot Olga, RUTKOWSKI JACEK. - J. Clin. Med. - 2022 : vol. 11, nr 9, art. ID 2591, s. 1-18, bibliogr. 104 poz., streszcz. ang.
  36. Analysis of efficacy and safety of vismodegib therapy in patients with advanced basal cell carcinoma - real world multicenter cohort study - Słowińska M., Dudzisz-Śledź M., Sobczuk P., Łasińska I., Pietruszka A., Cybulska-Stopa B., KOWALCZYK ANNA, Świtaj T., Czarnecka I., Koseła-Paterczyk H., Rogala P., Paluchowska E., Składowski K., Mackiewicz J., Rutkowski P., Owczarek W.. - J. Eur. Acad. Dermatol. Venereol. - 2022 : vol. 36, nr 8, s. 1219-1228, bibliogr. 31 poz., streszcz. ang.
  37. Loss of STING expression is prognostic in non-small cell lung cancer - Lohinai Zoltan, Dora David, Caldwell jr Charles, Rivard Christopher J., Suda Kenichi, Yu Hui, Rivalland Gareth, Ellison Kim, Rozeboom Leslie, DZIADZIUSZKO RAFAŁ, Mitchell Paul, John Thomas, Millan Inigo S., Ren Shengxiang, Hirsch Fred R.. - J. Surg. Oncol. - 2022 : vol. 125, nr 6, s. 1042-1052, bibliogr. 40 poz., streszcz. ang.
  38. Complex EGFR mutations in non-small cell lung cancer: a distinct entity? - BIEŃKOWSKI MICHAŁ, DZIADZIUSZKO RAFAŁ, JASSEM JACEK. - J. Thorac. Dis. - 2022 : vol. 14, nr 8, s. 2738-2741, bibliogr. 25 poz.
  39. STK11 and KEAP1 mutations in lung adenocarcinoma: solving the puzzle Continues - DZIADZIUSZKO RAFAŁ. - J. Thorac. Oncol. - 2022 : vol. 17, nr 3, s. 351-352, bibliogr. 5 poz.
  40. Brief report: exploratory analysis of maintenance therapy in patients with extensive-stage SCLC treated first line with atezolizumab plus carboplatin and etoposide - Reck Martin, Mok Tony S. K., Mansfield Aaron, De Boer Richard, Losonczy Gyorgy, Sugawara Shunichi, DZIADZIUSZKO RAFAŁ, Krzakowski Maciej, Smolin Alexey, Hochmair Maximilian, Garassino Marina Chiara, de Castro Junior Gilberto, Bischoff Helge, Lam Sivuonthanh, Cardona Andres, Morris Stefanie, Liu Stephen V.. - J. Thorac. Oncol. - 2022 : vol. 17, nr 9, s. 1122-1129, bibliogr. 19 poz., streszcz. ang.
  41. Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial - Yau Thomas, Park Joong-Won, Finn Richard S., Cheng Ann-Lii, Mathurin Philippe, Edeline Julien, Kudo Masatoshi, Harding James J., Merle Philippe, Rosmorduc Olivier, Wyrwicz Lucjan, Schott Eckart, Pin Choo Su, Kelley Robin Kate, Sieghart Wolfgang, Assenat Eric, ZAUCHA RENATA, Furuse Junji, Abou-Alfa Ghassan K., El-Khoueiry Anthony B., Melero Ignacio, Begic Damir, Chen Gong, Neely Jaclyn, Wisniewski Tami, Tschaika Marina, Sangro Bruno. - Lancet Oncol. - 2022 : vol. 23, nr 1, s. 77-90, bibliogr. 35 poz., streszcz. ang.
  42. European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer - Meattini Icro, Becherini Carlotta, Boersma Liesbeth, Kaidar-Person Orit, Gustavo Nader Marta, Montero Angel, Vrou Offersen Birgitte, Aznar Marianne C., Belka Claus, Brunt Murray Adrian, Dicuonzo Samantha, Franco Pierfrancesco, Krause Mechthild, Mackenzie Mairead, Marinko Tanja, Marrazzo Livia, Ratosa Ivica, Scholten Astrid, SENKUS ELŻBIETA, Stobart Hilary, Poortmans Philip, Coles Charlotte. - Lancet Oncol. - 2022 : vol. 23, nr 1, s. e21-e31, bibliogr. 68 poz., streszcz. ang.
  43. Continuous enzalutamide after progression of metastatic castration-resistant prostate cancer treated with docetaxel (PRESIDE) : an international, randomised, phase 3b study - Merseburger Axel S., Attard Gerhardt, Åström Lennart, Matveev Vsevolod B., Bracarda Sergio, Esen Adil, Feyerabend Susan, SENKUS ELŻBIETA, López-Brea Piqueras Marta, Boysen Gunther, Gourgiot Georgi, Martins Karla, Chowdhury Simon. - Lancet Oncol. - 2022 : vol. 23, nr 11, s. 1398-1408, bibliogr. 28 poz., streszcz. ang.
  44. Patient-reported outcomes with olaparib plus abiraterone versus placebo plus abiraterone for metastatic castrationresistant prostate cancer : a randomised, double-blind, phase 2 trial - Saad Fred, Thiery-Vuillemin Antoine, Wiechno Pawel, Alekseev Boris, Sala Nuria, Jones Robert, Kocak Ivo, Chiuri Vincenzo Emanuele, JASSEM JACEK, Fléchon Aude, Redfern Charles, Kang Jinyuv, Burgents Joseph, Gresty Christopher, Degboe Arnold, Clarke Noel W. - Lancet Oncol. - 2022 : vol. 23, nr 10, s. 1297-1307, bibliogr. 30 poz., streszcz. ang.
  45. Pre- and post-treatment blood-based genomic landscape of patients with ROS1 or NTRK fusion-positive solid tumours treated with entrectinib - DZIADZIUSZKO RAFAŁ, Hung Tiffany, Wang Kun, Choeurng Voleak, Drilon Alexander, Doebele Robert C., Barlesi Fabrice, Wu Charlie, Dennis Lucas, Skoletsky Joel, Woodhouse Ryan, Li Meijuan, Chang Ching-Wei, Simmons Brian, Riehl Todd, Wilson Timothy R.. - Mol. Oncol. - 2022 : vol.16, nr 10, s. 2000-2014, bibliogr. 43 poz., streszcz. ang.
  46. Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden : primary analysis of BFAST cohort C randomized phase 3 trial - Peters Solange, DZIADZIUSZKO RAFAŁ, Morabito Alessandro, Felip Enriqueta, Gadgeel Shirish M., Cheema Parneet, Cobo Manuel, Andric Zoran, Barrios Carlos H., Yamaguchi Masafumi, Dansin Eric, Danchaivijitr Pongwut, Johnson Melissa, Novello Silvia, Mathisen Michael S., Shagan Sarah M., Schleifman Erica, Wang Jin, Yan Mark, Mocci Simonetta, Voong David, Fabrizio David A., Shames David S., Riehl Todd, Gandara David R., Mok Tony. - Nat. Med. - 2022 : vol. 28, nr 9, s. 18311839, bibliogr. 49 poz., streszcz. ang.
  47. Thoracic neoplasms - Krzakowski Maciej, JASSEM JACEK, Antczak Adam, Błasińska Katarzyna, Chrostowska-Wynimko Joanna, DZIADZIUSZKO RAFAŁ, Głogowski Maciej, Grodzki Tomasz, Kowalski Dariusz, Krenke Rafał, Langfort Renata, Olszewski Włodzimierz, Orłowski Tadeusz, Śliwiński Paweł, Tysarowski Andrzej, RZYMAN WITOLD, Woźniewski Marek. - Oncol. Clin. Pract. - 2022 : vol 18, nr 1, s. 1-39, bibliogr. 164 poz.
  48. High expression of progesterone receptor may be an adverse prognostic factor in oestrogen receptor-negative/ progesterone receptor-positive breast cancer: results of comprehensive re-evaluation of multi-institutional case series - KUNC MICHAŁ, PĘKSA RAFAŁ, Cserni Gabor, IŻYCKA-ŚWIESZEWSKA EWA, Łacko Aleksandra, Radecka Barbara, Braun Marcin, Pikiel Joanna, Litwiniuk Maria, Pogoda Katarzyna, Szwajkosz Anna, BIERNAT WOJCIECH, SENKUS ELŻBIETA. - Pathology - 2022 : vol. 54, nr 3, s. 269-278, bibliogr. 31 poz., streszcz. ang.
  49. The clinician's guide to radiotherapy complications - Fendler Wojciech, TOMASIK BARTŁOMIEJ, Atkins Katelyn, Stawiski Konrad, Chałubińska-Fendler Justyna, Kozono David. - Pol. Arch. Med. Wewn. - 2022 : vol. 132, nr 1, art. ID 16190, s. 1-11, bibliogr. 100 poz., streszcz. ang.
  50. Conventionally fractionated radiotherapy versus CyberKnife hypofractionated radiotherapy for painful vertebral haemangiomas - a randomized clinical trial - Miszczyk Marcin, Napieralska Aleksandra, Woźniak Grzegorz, Kraszkiewicz Małgorzata, Gola Michał, Kalemba Michał, Głowacki Grzegorz, TOMASIK BARTŁOMIEJ, Kocot-Kępska Magdalena, Miszczyk Leszek. - Radiother. Oncol. - 2022 : vol. 176, s. 46-52, bibliogr. 26 poz., streszcz. ang.
  51. Induction of 2-hydroxycatecholestrogens O-methylation: A missing puzzle piece in diagnostics and treatment of lung cancer - MUSIAŁ CLAUDIA, KNAP NARCYZ, ZAUCHA RENATA, BASTIAN PAULINA, Barone Giampaolo, Lo Bosco Giosuè, Lo-Celso Fabrizio, KONIECZNA LUCYNA, BELKA MARIUSZ, BĄCZEK TOMASZ, Gammazza Antonella Marino, KUBAN-JANKOWSKA ALICJA, Cappello Francesco, Nussberger Stephan, GÓRSKA-PONIKOWSKA MAGDALENA. - Redox Biol. - 2022 : vol. 55, art. ID 102395, s. 1-13, bibliogr. 104 poz., streszcz. ang.
  52. Pathway-level mutation analysis in primary high-grade serous ovarian cancer and matched brain metastases - Duchnowska Renata, SUPERNAT ANNA MARIA, PĘKSA RAFAŁ, Łukasiewicz Marta, STOKOWY TOMASZ, Ronen Ron, Dutkowski Janusz, Umińska Monika, IŻYCKA-ŚWIESZEWSKA EWA, KOWALCZYK ANNA, Och Waldemar, Rucińska Monika, Olszewski Wojciech P., Mandat Tomasz, Jarosz Bożena, BIEŃKOWSKI MICHAŁ, BIERNAT WOJCIECH, JASSEM JACEK. - Sci. Rep. - 2022 : vol. 12, art. ID 20537, s. 1-9, bibliogr. 53 poz., streszcz. ang.
  53. Results of screening in early and advanced thoracic malignancies in the EORTC pan-European SPECTAlung platform - Morfouace M., Novello S., Stevovic A., Dooms C., Janžič U., Berghmans T., DZIADZIUSZKO RAFAŁ, Gorlia T., Felip E., Paz-Ares L., Mazieres J., O'Brien M., Bironzo P., Vansteenkiste J., Lacroix L., Dingemans A.C., Golfinopoulos V., Besse B.. - Sci. Rep. - 2022 : vol. 12, art. ID 8342, s. 1-11, bibliogr. 15 poz., streszcz. ang.
  54. Lung cancer in Europe: The way forward - Racovita Monica, Wheeler Eleanor, Wait Suzanne, Bancroft Dani, Eastabrook Rowan, Albreht Tit, Baird Anne-Marie, JASSEM JACEK, McNamara Aoife, Novello Silvia, Radu-Loghin Cornel, Van Meerbeeck Jan P.. - Tob. Prev. Cessation - 2022 : vol. 8, s. 1-2, bibliogr. 13 poz.
  55. Design of a multinational randomized controlled trial to assess the effects of structured and individualized exercise in patients with metastatic breast cancer on fatigue and quality of life: the EFFECT study - Hiensch Anouk E., Monninkhof Evelyn M., Schmidt Martina E., Zopf Eva M., Bolam Kate A., Aaronson Neil K., Belloso Jon, Bloch Wilhelm, Clauss Dorothea, Depenbusch Johanna, LACHOWICZ MILENA, Pelaez Mireia, Rundqvist Helene, SENKUS ELŻBIETA, Stuiver Martijn M., Trevaskis Mark, Urruticoechea Ander, Rosenberger Friederike, van der Wall Elsken, de Wit G. Ardine, Zimmer Philipp, Wengström Yvonne, Steindorf Karen, May Anne M.. - Trials - 2022 : vol. 23, art. ID 610, s. 1-14, bibliogr. 50 poz., streszcz. ang.
  56. Antibiotic-related adverse drug reactions in patients treated on the Dermatology Ward of Medical University of Gdańsk - Sokolewicz Ewa Maria, Rogowska Martyna, Lewandowski Miłosz, PUCHOWSKA MONIKA, Piechota Dorota, BARAŃSKA-RYBAK WIOLETTA. - Antibiotics - 2021 : vol. 10, nr 10, art. ID 1144, s. 1-8, bibliogr. 35 poz., streszcz. ang.
  57. Patterns of use of a trastuzumab biosimilar (ABP 980) in patients with HER2+ breast cancer treated in clinical practice in Europe: an interim analysis from an observational chart review study (GARDENIA) - Kufel-Grabowska Joanna, San Tevy, Bernardo Antonio, Cavanna Luigi, Fernandez Perez Isaura, SUCHODOLSKA GRAŻYNA, Hippenmeyer Jane, Gokani Priya, Lillie Mark, Rodriguez César A.. - Cancer Res. - 2021 : vol. 81, nr 4, suppl., abs. PS10-50
  58. Patient eligibility and results for brain metastasis in phase 3 trials of advanced breast cancer : a scoping review - Duchnowska Renata, Saad Everardo D., Banaszek Małgorzata, PAWŁOWSKA EWA, Liberek Hanna, CICHOWSKA-CWALIŃSKA NATALIA, JASSEM JACEK. - Cancers - 2021 : vol. 13, nr 21, art. ID 5306, s. 1-9, bibliogr. 30 poz., streszcz. ang.
  59. Adjuvant vaginal cuff brachytherapy in surgically treated endometrial carcinoma patients : in view of the recent evidence - SERKIES KRYSTYNA, BACZKOWSKA-WALISZEWSKA ZUZANNA. - J. Contemp. Brachyther. - 2021 : vol. 13, nr 2, s. 221-230, bibliogr. 44 poz., streszcz. ang.
  60. Concurrent chemoradiotherapy for stage III non-small-cell lung cancer: recent progress and future perspectives (a narrative review) - ŁAZAR-PONIATOWSKA MAŁGORZATA, BANDURA ARTUR, DZIADZIUSZKO RAFAŁ, JASSEM JACEK. - Transl. Lung Cancer Res. - 2021 : vol. 10, nr 4, s. 2018-2031, bibliogr. 81 poz., streszcz., ang.
  61. Activation of epithelial-mesenchymal transition process during breast cancer progression : the impact of molecular subtype and stromal composition - MARKIEWICZ ALEKSANDRA, TOPA JUSTYNA, POPĘDA MARTA, SZADE JOLANTA, SKOKOWSKI JAROSŁAW, WEŁNICKA-JAŚKIEWICZ MARZENA, ŻACZEK ANNA. - Acta Biochim. Pol. - 2021 : vol. 68, nr 3, s. 385-395, bibliogr. [57] poz., streszcz. ang.
  62. Comparative efficacy of cabozantinib and ramucirumab after sorafenib for patients with hepatocellular carcinoma and alpha-fetoprotein >= 400ng/mL : a matching-adjusted indirect comparison - Trojan Jörg, Mollon Patrick, Daniele Bruno, Marteau Florence, Martín Lidia, Li Yuxin (obcy), Xu Qing, Piscaglia Fabio, ZAUCHA RENATA, Sarker Debashis, Lim Ho Yeong, Venerito Marino. - Adv. Ther. - 2021 : vol. 38, nr 5, s. 2472-2490, bibliogr. 34 poz., streszcz. ang.
  63. Analysis of mutation status and homologous recombination deficiency in tumors of patients with germline BRCA1 or BRCA2 mutations and metastatic breast cancer : OlympiAD - Hodgson D., Lai Z., Dearden S., Barrett J. C., Harrington E. A., Timms K., Lanchbury J., Wu W., Allen A., SENKUS ELŻBIETA, Domchek S. M., Robson M.. - Ann. Oncol. - 2021 : vol. 32, nr 12, s. 1582-1589, bibliogr. 21 poz., streszcz. ang.
  64. Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer : updated efficacy and Ki-67 analysis from the monarchE study - Harbeck N., Rastogi P., Martin M., Tolaney S. M., Shao Z. M., Fasching P. A., Huang C. S., Jaliffe G. G., Tryakin A., Goetz M. P., Rugo H. S., SENKUS ELŻBIETA, Testa L., Andersson M., Tamura K., Del Mastro L., Steger G. G., Kreipe H., Hegg R., Sohn J., Guarneri V., Cortés J., Hamilton E., André V., Wei R., Barriga S., Sherwood S., Forrester T., Munoz M., Shahir A., San Antonio B., Nabinger S. C., Toi M., Johnston S. R. D., O'Shaughnessy J.. - Ann. Oncol. - 2021 : vol. 32, nr 12, s. 1571-1581, bibliogr. 29 poz., streszcz. ang.
  65. Pharmacokinetics and safety of rucaparib in patients with advanced solid tumors and hepatic impairment - Grechko Nikolay, Skarbova Viera, Tomaszewska-Kiecana Monika, Ramlau Rodryg, Centkowski Piotr, Drew Yvette, DZIADZIUSZKO RAFAŁ, Zemanova Milada, Beltman Jeri, Nash Eileen, Habeck Jenn, Liao Mingxiang, Xiao Jim. - Cancer Chemother. Pharmacol. - 2021 : vol. 88, nr 2, s. 259-270, bibliogr. 28 poz., streszcz. ang.
  66. De-escalation of axillary irradiation for early breast cancer - Has the time come? - SENKUS ELŻBIETA, Cardoso Maria Joao, Kaidar-Person Orit, Łacko Aleksandra, Meattini Icro, Poortmans Philip. - Cancer Treat. Rev. - 2021 : vol. 101, art. ID 102297, s. 1-9, bibliogr. 85 poz., streszcz. ang.
  67. Systematic review of real-world studies evaluating the impact of medication non-adherence to endocrine therapies on hard clinical endpoints in patients with non-metastatic breast cancer - Inotai András, Ágh Tamás, Maris Ramona, Erdösi Dalma, Kovács Sándor, Kaló Zoltán, SENKUS ELŻBIETA. - Cancer Treat. Rev. - 2021 : vol. 100, art. ID 102264, s. 1-9, bibliogr. 73 poz., streszcz. ang.
  68. Molecular profiles of brain metastases : a focuson heterogeneity - Ali Shan, Zagórska Zuzanna, Duchnowska Renata, JASSEM JACEK. - Cancers - 2021 : vol. 13, nr 11, art. ID 2645, s. 1-12, bibliogr. 92 poz., streszcz. ang.
  69. Lost but not least : novel insights into progesterone receptor loss in estrogen receptor : positive breast cancer - KUNC MICHAŁ, POPĘDA MARTA, BIERNAT WOJCIECH, SENKUS ELŻBIETA. - Cancers - 2021 : vol. 13, nr 19, art. ID 4755, s. 1-18, bibliogr. 126 poz., streszcz. ang.
  70. High-grade gliomas in children : a multi-institutional Polish study - Napieralska Aleksandra, Krzywon Aleksandra, Mizia-Malarz Agnieszka, Sosna-Zielińska Joanna, PAWŁOWSKA EWA, KRAWCZYK MAŁGORZATA, Konat-Bąska Katarzyna, Kaczorowska Aneta, Dąbrowska Anna, Harat Maciej. - Cancers - 2021 : vol. 13, nr 9, art. ID 2062, s. 1-15, bibliogr. 68 poz., streszcz. ang.
  71. Diagnostic accuracy of liquid biopsy in endometrial cancer - ŁUKASIEWICZ MARTA, Pastuszak Krzysztof, ŁAPIŃSKA-SZUMCZYK SYLWIA, Różański Robert, In t Veld Sjors G. J. G., BIEŃKOWSKI MICHAŁ, STOKOWY TOMASZ, RATAJSKA MAGDALENA, Best Myron G., Würdinger Thomas, ŻACZEK ANNA J., SUPERNAT ANNA, JASSEM JACEK. - Cancers - 2021 : vol. 13, nr 22, art. ID 5731, s. 1-11, bibliogr. 42 poz., streszcz. ang.
  72. Polish multi-institutional study of children with ependymoma : clinical practice outcomes in the light of prospective trials - Napieralska Aleksandra, Mizia-Malarz Agnieszka, Stolpa Weronika, PAWŁOWSKA EWA, KRAWCZYK MAŁGORZATA A., Konat-Bąska Katarzyna, Kaczorowska Aneta, Brąszewski Arkadiusz, Harat Maciej. - Diagnostics - 2021 : vol. 11, nr 2, art. ID 2360, s. 1-22, bibliogr. 85 poz., streszcz. ang.
  73. Predictive factors testing proposal for NSCLC patients during the COVID-19 pandemic - Krawczyk Pawel, Kowalski Dariusz M., Wojas-Krawczyk Kamila, DZIADZIUSZKO RAFAŁ. - Expert Rev. Anticancer Ther. - 2021 : vol. 21, nr 6, s. 569-572, bibliogr. 14 poz. ang.
  74. Molecularly targeted therapies in adult type gliomas - SZUTOWICZ-ZIELIŃSKA EWA. - Folia Neuropathol. - 2021 : vol. 59, nr 4, s. 423
  75. Case report: adjuvant radiotherapy can be an effective treatment for intimal sarcoma of the heart - Romanowska Anna, LEWICKA EWA, SŁAWIŃSKI GRZEGORZ, JANKOWSKA HANNA, ZAUCHA RENATA. - Front. Oncol. - 2021 : vol. 11, art. ID 621289, s. 1-7, bibliogr. 26 poz., streszcz. ang.
  76. A network meta-analysis of cancer immunotherapies Versus chemotherapy for first-line treatment of patients with non-small cell lung cancer and high programmed death-ligand 1 expression - Herbst Roy, JASSEM JACEK, Abogunrin Seye, James Daniel, McCool Rachael, Belleli Rossella, Giaccone Giuseppe, de Marinis Filippo. - Front. Oncol. - 2021 : vol. 11, art. ID 676732, s. 1-12, bibliogr. 39 poz., streszcz. ang.
  77. DUART: durvalumab after radiotherapy in patients with unresectable, stage III NSCLC who are ineligible for chemotherapy - Filippi Andrea R, DZIADZIUSZKO RAFAŁ, Gracia Campelo Maria Rosario, Paoli Jean-Baptiste, Sawyer William, Diaz Pérez Ignacio Esteban. - Future Oncol. - 2021 : vol. 17, nr 34, s. 4657-4663, bibliogr. 19 poz., streszcz. ang.
  78. Plausible role of estrogens in pathogenesis, progression and therapy of lung cancer - MUSIAŁ CLAUDIA, ZAUCHA RENATA, KUBAN-JANKOWSKA ALICJA, KONIECZNA LUCYNA, BELKA MARIUSZ, Gammazza Antonella Marino, BĄCZEK TOMASZ, Cappello Francesco, WOŹNIAK MICHAŁ, GÓRSKA-PONIKOWSKA MAGDALENA. - Int. J. Environ. Res. Public Health - 2021 : vol. 18, nr 2, art. ID 648, s. 1-15, bibliogr. 101 poz., streszcz. ang.
  79. Safety of surgery after neoadjuvant targeted therapies in non-small cell lung cancer : a narrative review - MARJAŃSKI TOMASZ, DZIEDZIC ROBERT, KOWALCZYK ANNA, RZYMAN WITOLD. - Int. J. Mol. Sci. - 2021 : vol. 22, nr 22, art. ID 12244, s. 1-14, bibliogr. 96 poz., streszcz. ang.
  80. Successful treatment of persistent SARS-CoV-2 infection in a B-cell depleted patient with activated cytotoxic T and NK cells : a case report - JASSEM JACEK, MAREK-TRZONKOWSKA NATALIA MARIA, SMIATACZ TOMASZ, Arcimowicz Łukasz, Papak Ines, JASSEM EWA, ZAUCHA JAN. - Int. J. Mol. Sci. - 2021 : vol. 22, nr 20, art. ID 10934, s. 1-13, bibliogr. 27 poz., streszcz. ang.
  81. A view from the past into our collective future : the oncofertility consortium vision statement - Woodruff Teresa K., Ataman-Millhouse Lauren, Acharya Kelly S., Almeida-Santos Teresa, Anazodo Antoinette, Anderson Richard A., Appiah Leslie, Bader Joy, Becktell Kerri, Brannigan Robert E., Breech Lesley, Bourlon Maria T., Bumbuliene Žana, Burns Karen, Campo-Engelstein Lisa, Campos Jacira R., Centola Grace M., Chehin Mauricio Barbour, Chen Diane, De Vos Michel, Duncan Francesca E., El-Damen Ahmed, Fair Douglas, Famuyiwa Yemi, Fechner Patricia Y., Fontoura Paula, Frias Olivia, Gerkowicz Sabrina A., Ginsberg Jill, Gracia Clarisa R., Goldman Kara, Gomez-Lobo Veronica, Hazelrigg Brent, Hsieh Michael H., Hoyos Luis R., Hoyos-Martinez Alfonso, Jach Robert, JASSEM JACEK, Javed Murid, Jayasinghe Yasmin, Jeelani Roohi, Jeruss Jacqueline S., Kaul-Mahajan Nalini, Keim-Malpass Jessica, Ketterl Tyler G., Khrouf Mohamed, Kimelman Dana, Kusuhara Atsuko, Kutteh William H., Laronda Monica M. (obcy), Lee Jung Ryeol, Lehmann Vicky, Letourneau Joseph M., McGinnis Lynda K, McMahon Eileen, Meacham Lillian R., Mijangos Monserrat Fabiola V., Moravek Molly, Nahata Leena, Ogweno George Moses, Orwig Kyle E., Pavone Mary Ellen, Peccatori Fedro Alessandro, Pesce Romina Ileana, Pulaski Hanna, Quinn Gwendolyn, Quintana Ramiro, Quintana Tomas, de Carvalho Bruno Ramalho, Ramsey-Goldman Rosalind, Reinecke Joyce, Reis Fernando M., Rios Julie, Rhoton-Vlasak Alice S., Rodriguez-Wallberg Kenny A., Roeca Cassandra, Rotz Seth J., Rowell Erin, Salama Mahmoud, Saraf Amanda J., Scarella Anibal, Schafer-Kalkhoff Tara, Schmidt Deb, Senapati Suneeta, Shah Divya, Shikanov Ariella, Shnorhavorian Margarett, Skiles Jodi L., Smith James F., Smith Kristin, Sobral Fabio, Stimpert Kyle, Su H. Irene, Sugimoto Kouhei, Suzuki Nao, Thakur Mili (obcy), Victorson David, Viale Luz, Vitek Wendy, Wallace W. Hamish, Wartella Ellen A., Westphal Lynn M., Whiteside Stacy, Wilcox Lea H., Wyns Christine, Xiao Shuo, Xu Jing, Zelinski Mary. - J. Assist. Reprod. Genet. - 2021 : vol. 38, nr 1, s. 3-15, bibliogr. 76 poz., streszcz. ang.
  82. The European Code of Cancer Practice - Lawler Mark, Oliver Kathy, Gijssels Stefan, Aapro Matti, Abolina Agnese, Albreht Tit, Erdem Sema, Geissler Jan, JASSEM JACEK, Karjalainen Sakari, La Vecchia Carlo, Lievens Yolande, Meunier Françoise, Morrissey Mike, Naredi Peter, Oberst Simon, Poortmans Philip, Price Richard, Sullivan Richard, Velikova Galina, Vrdoljak Eduard, Wilking Nils, Yared Wendy, Selby Peter. - J. Cancer Policy - 2021 : vol. 28, art. ID 100282, s. 1-20, bibliogr. 218 poz., streszcz. ang.
  83. The anatomical conditions of the alveolar process of the anterior maxilla in terms of immediate implantation : radiological retrospective case series study - Wychowański Piotr, STARZYŃSKA ANNA, Osiak Martyna, Kowalski Jan, Jereczek-Fossa Barbara Alicja, SEKLECKA BLANKA, Morawiec Tadeusz, ADAMSKA PAULINA, Woliński Jarosław. - J. Clin. Med. - 2021 : vol. 10, nr 8, art. ID 1688, s. 1-13, bibliogr. 48 poz., streszcz. ang.
  84. Updated integrated analysis of the efficacy and safety of entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small-cell lung cancer - DZIADZIUSZKO RAFAŁ, Krebs Matthew G., de Braud Filippo, Siena Salvatore, Drilon Alexander, Doebele Robert C., Patel Manish R., Cho Byoung Chul, Liu Stephen V., Ahn Myung-Ju, Chiu Chao-Hua, Farago Anna F., Lin Chia-Chi, Karapetis Christos S., Li Yu-Chung, Day Bann-mo, Chen David, Wilson Timothy R., Barlesi Fabrice. - J. Clin. Oncol. - 2021 : vol. 39, nr 11, s. 1253-1263, bibliogr. 20 poz., streszcz. ang.
  85. Prognostic significance of Wnt1, Wnt2, E-cadherin, and β-catenin expression in operable non-small cell lung cancer - WRONA ANNA, Sejda Aleksandra, DZIADZIUSZKO RAFAŁ, JASSEM JACEK. - J. Histochem. Cytochem. - 2021 : vol. 69, nr 11, s. 711-722, bibliogr. 44 poz., streszcz. ang.
  86. Outcomes according to ALK status determined by central immunohistochemistry or fluorescence in situ hybridization in patients with ALK-positive NSCLC enrolled in the phase 3 ALEX study - Mok Tony, Peters Solange, Camidge Ross, Noé Johannes, Gadgeel Shirish, Ignatius Sai-Hong, Kim Dong-Wan, KONOPA KRZYSZTOF, Pozzi Emanuela, Liu Ting, Loftin Isabell R., Williams Crystal, Shaw Alice T.. - J. Thorac. Oncol. - 2021 : vol. 16, nr 2, s. 259-268, bibliogr. 28 poz., streszcz. ang.
  87. Prognostic impact of KRAS G12C mutation in patients with NSCLC : results from the European Thoracic Oncology Platform Lungscape Project - Finn Stephen P., Addeo Alfredo, Dafni Urania, Thunnissen Erik, Bubendorf Lukas, Madsen Line Bille, BIERNAT WOJCIECH, Verbeken Erik, Hernandez-Losa Javier, Marchetti Antonio, Cheney Richard, Warth Arne, Speel Ernst-Jan M., Quinn Anne Marie, Monkhorst Kim, Jantus-Lewintre Eloisa, Tischler Verena, Marti Nesa, Dimopoulou Georgia, Molina-Vila Miguel A., Kammler Roswitha, Kerr Keith M., Peters Solange, Stahel Rolf A., , DZIADZIUSZKO RAFAŁ, BIERNAT WOJCIECH, WRONA ANIA, JASSEM JACEK. - J. Thorac. Oncol. - 2021 : vol. 16, nr 6, s. 990-1002, bibliogr. 25 poz., streszcz. ang.
  88. Updated overall survival analysis from IMpower110 : atezolizumab versus platinum-based chemotherapy in treatment-naive programmed death-ligand 1-selected NSCLC - JASSEM JACEK, de Marinis Filippo, Giaccone Giuseppe, Vergnenegre Alain, Barrios Carlos H., Morise Masahiro, Felip Enriqueta, Oprean Cristina, Kim Young-Chul, Andric Zoran, Mocci Simonetta, Enquist Ida, Komatsubara Kimberly, McCleland Mark, Kuriki Hiroshi, Villalobos Monette, Phan See, Spigel David R., Herbst Roy S.. - J. Thorac. Oncol. - 2021 : vol. 16, nr 11, s. 1872-1882, bibliogr. 22 poz., streszcz. ang.
  89. Blood First Assay Screening Trial (BFAST) in treatment-naive advanced or metastatic NSCLC : initial results of the phase 2 ALK-positive cohort - DZIADZIUSZKO RAFAŁ, Mok Tony, Peters Solange, Han Ji-Youn, Alatorre-Alexander Jorge, Leighl Natasha, Sriuranpong Virote, Pérol Maurice, de Castro Junior Gilberto, Nadal Ernest, de Marinis Filippo, Arén Frontera Osvaldo, Tan Daniel S. W., Lee Dae Ho, Kim Hye Ryun, Yan Mark, Riehl Todd, Schleifman Erica, Paul Sarah M., Mocci Simonetta, Patel Rajesh, Assaf Zoe June, Shames David S., Mathisen Michael S., Gadgeel Shirish M.. - J. Thorac. Oncol. - 2021 : vol. 16, nr 12, s. 2040-2050, bibliogr. 28 poz., streszcz. ang.
  90. Authors reply to role of primary prevention in lung cancer control in Poland - DZIADZIUSZKO RAFAŁ, Didkowska Joanna, JASSEM JACEK. - J. Thorac. Oncol. - 2021 : vol. 16, nr 10, s. e94-e95, bibliogr. 4 poz., streszcz. ang.
  91. Liquid biopsy for advanced NSCLC: a consensus statement from the International Association for the Study of Lung Cancer - Rolfo Christian, Mack Philip, Scagliotti Giorgio V., Aggarwal Charu, Arcila Maria E., Barlesi Fabrice, Bivona Trever, Diehn Maximilian, DZIADZIUSZKO RAFAŁ, Leighl Natasha, Malapelle Umberto, Mok Tony, Peled Nir, Raez Luis E., Sequist Lecia, Sholl Lynette, Swanton Charles, Abbosh Chris, Tan Daniel, Wakelee Heather, Wistuba Ignacio, Bunn Rebecca, Freeman-Daily Janet, Wynes Murry, Belani Chandra, Mitsudomi Tetsuya, Gandara David. - J. Thorac. Oncol. - 2021 : vol. 16, nr 10, s. 1647-1662, bibliogr. 123 poz., streszcz. ang.
  92. Effectiveness and safety of immunotherapy in NSCLC patients with ECOG PS score >=2 : systematic review and meta-analysis - Tomasik Bartłomiej, BIEŃKOWSKI MICHAŁ, Braun Marcin, Popat Sanjay, DZIADZIUSZKO RAFAŁ. - Lung Cancer - 2021 : vol. 158, s. 97-106, bibliogr. 104 poz., streszcz. ang.
  93. imPlatelet classifier: image-converted RNA biomarker profiles enable blood-based cancer diagnostics - Pastuszak Krzysztof, SUPERNAT ANNA, Best Myron G., In 't Veld Sjors G. J. G., ŁAPIŃSKA-SZUMCZYK SYLWIA, ŁOJKOWSKA ANNA, Różański Robert, ŻACZEK ANNA J., JASSEM JACEK, Thomas Wüurdinger Thomas, STOKOWY TOMASZ. - Mol. Oncol. - 2021 : vol. 15, nr 10, s. 2688-2701, bibliogr. 48 poz., streszcz. ang.
  94. Using DNA sequencing data to quantify T cell fraction and therapy response - Bentham Robert, Litchfield Kevin, Watkins Thomas B. K., Lim Emilia L., Rosenthal Rachel, Martinez-Ruiz Carlos, Hiley Crispin T., Al Bakir Maise, Salgado Roberto, Moore David A., Jamal-Hanjani Mariam, Swanton Charles, McGranahan Nicholas, , SKRZYPSKI MARCIN. - Nature - 2021 : vol. 597, nr 7877, s. 555-560, bibliogr. 56 poz., streszcz. ang.
  95. Comparison of claudin-3 and claudin-4 expression in bilateral and unilateral breast cancer - SZADE JOLANTA, KUNC MICHAŁ, PIECZYŃSKA-UZIĘBŁO BEATA, ŚWIERBLEWSKI MACIEJ, BIERNAT WOJCIECH, JASSEM JACEK, SENKUS ELŻBIETA. - Neoplasma - 2021 : vol. 68, nr 2, s. 283-289, bibliogr. 26 poz., streszcz. ang.
  96. Adjuvant olaparib for patients with BRCA1- or BRCA2-mutated breast cancer - Tutt A.N.J., Garber J.E., Kaufman B., Viale G., Fumagalli D., Rastogi P., Gelber R.D., de Azambuja E., Fielding A., Balmana J., Domchek S.M., Gelmon K.A., Hollingsworth S.J., Korde L.A., Linderholm B., Bandos H., SENKUS ELŻBIETA, Suga J.M., Shao Z., Pippas A.W., Nowecki Z., Huzarski T., Ganz P.A., Lucas P.C., Baker N., Loibl S., McConnell R., Piccart M., Schmutzler R., Steger G.G., Costantino J.P., Arahmani A., Wolmark N., McFadden E., Karantza V., Lakhani S.R., Yothers G., Campbell C., Geyer, Jr. C.E.. - New Eng. J. Med. - 2021 : vol. 384, nr 25, s. 2394-2405, bibliogr. 36 poz., streszcz. ang.
  97. Role of radiotherapy in the management of brain metastases of NSCLC : decision criteria in clinical routine - Glatzer Markus, Faivre-Finn Corinne, De Ruysscher Dirk, Widder Joachim, Van Houtte Paul, Troost Esther G.C., Slotman Ben J., Ramella Sara, Pöttgen Christoph, Peeters Stephanie T.H., Nestle Ursula, McDonald Fiona, Le Pechoux Cecile, DZIADZIUSZKO RAFAŁ, Belderbos José, Ricardi Umberto, Manapov Farkhad, Lievens Yolande, Geets Xavier, Dieckmann Karin, Guckenberger Matthias, Andratschke Nicolaus, Süveg Krisztian, Putora Paul M.. - Radiother. Oncol. - 2021 : vol. 154, s. 269-273, bibliogr. 22 poz., streszcz. ang.
  98. Transcriptomic landscape of blood platelets in healthy donors - SUPERNAT ANNA, POPĘDA MARTA, Pastuszak Krzysztof, Best Myron G., GREŠNER PETER, In 't Veld Sjors, SIEK BARTŁOMIEJ, BEDNARZ-KNOLL NATALIA, Rondina Matthew T., STOKOWY TOMASZ, Wurdinger Thomas, JASSEM JACEK, ŻACZEK ANNA J.. - Sci. Rep. - 2021 : vol. 11, art. ID 15679, s. 1-10, bibliogr. 42 poz., streszcz. ang.
  99. Hypofractionation in early stage non-small cell lung cancer - WRONA ANNA, Mornex Francoise. - Semin. Radiat. Oncol. - 2021 : vol. 31, nr 2, s. 97-104, bibliogr. 94 poz., streszcz. ang.
  100. Radiotherapy in thoracic malignancies: the preface - JASSEM JACEK, DZIADZIUSZKO RAFAŁ. - Transl. Lung Cancer Res. - 2021 : vol. 10, nr 4, s. 1928-1929
  101. Correlations between peripheral blood biomarkers and clinical outcomes in advanced non-small cell lung cancer patients who received immunotherapy-based treatments - Shi Yuequan, Liu Xiaoyan, Zhang Dongming, Liu Xiangning, Yue Yuan, Zhou Qing, Gao Xiaoxing, Chen Minjiang, Xu Yan, Zhao Jing, Zhong Wei, Provencio Mariano, JASSEM JACEK, Williams Terence M., Seeber Andreas, Kocher Florian, Wang Mengzhao. - Transl. Lung Cancer Res. - 2021 : vol. 10, nr 12, s. 4477-4493, bibliogr. 46 poz., streszcz., ang.
  102. Combining radiotherapy with targeted therapies in non-small cell lung cancer: focus on anti-EGFR, anti-ALK and anti-angiogenic agents - WRONA ANNA, DZIADZIUSZKO RAFAŁ, JASSEM JACEK. - Transl. Lung Cancer Res. - 2021 : vol. 10, nr 4, s. 2032-2047, bibliogr. 92 poz., streszcz., ang.
  103. Artificial intelligence-based analysis for immunohistochemistry staining of immune checkpoints to predict resected non-small cell lung cancer survival and relapse - Guo Haoyue, Li Diao, Zhou Xiaofeng, Chen Jie-Neng, Zhou Yue, Fang Qiyu, He Yayi, DZIADZIUSZKO RAFAŁ, Zhou Caicun, Hirsch Fred R.. - Transl. Lung Cancer Res. - 2021 : vol. 10, nr 6, s. 2452-2474, bibliogr. 47 poz., streszcz., ang.
  104. ALK alterations in salivary gland carcinomas - Majewska Hanna, GORCZYŃSKI ADAM, Czapiewski Piotr, Menon Roopika, Mueller Judith, Lakis Sotirios, Heuckmann Johannes M., Laco Jan, Gupta Ruta, Andreasen Simon, STODULSKI DOMINIK, ILISZKO MARIOLA, DZIADZIUSZKO RAFAŁ, JASSEM JACEK, Heukamp Lukas C., BIERNAT WOJCIECH. - Virchows Arch. - 2021 : vol. 478, nr 3, s. 933-941, bibliogr. 37 poz., streszcz. ang.
Aktualizacja strony: 07.02.2023
Helpdesk IT